Clinical Oncology: Year 2019 in Review
The clinical practice of oncology is a rapidly-evolving discipline. This program will provide physicians – especially oncologists, gynecologic oncologists, hematologists, radiation oncologists, and surgical oncologists – as well as cancer-interested dermatologists, gastroenterologists, nephrologists, pulmonologists, urologists, nurse practitioners and physician assistants, with a summary of the latest advances in discipline-related cancers. New therapeutic agents will be a topic of discussion. This program will focus on how these new advances will impact the practice of oncology today.
Updates in the Management of Breast Cancer
Shipra Gandhi, MD, provides updates on neoadjuvant, adjuvant and metastatic therapies for the treatment of HER2-positive breast cancer, hormone receptor positive breast cancer, and triple negative breast cancer.Breast and Early Phase Clinical Trials, Department of Medicine
Updates in the Management of GI Malignancies
Christos Fountzilas, MD, discusses updates in GI malignancies. This lecture covers esophagogastric cancer, pancreatic cancer, colorectal cancer, neuroendocrine tumors, hepatocellular carcinoma and cholangiocarcinoma.Department of Medicine, GI Center
New Drugs and Promising Combinations
Out of the many of new drugs in development, Igor Puzanov, MD, MSCI, FACP, selected those that seem the most promising. In this lecture he will discuss the novel classes of promising agents in development, how to enhance immune response ...Professor of Oncology, Department of Medicine
Director, Center for Early Phase Clinical Trials
Chief, Early Phase Clinical Trials Division
Chief, Melanoma Section
Updates in Lung Cancer Treatments
Edwin Yau, MD, PhD, discusses metastatic lung cancers and provides updates on new FDA approvals.Department of Medicine
Department of Cancer Genetics & Genomics